Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2009
03/11/2009CN101384581A Benzoyl-piperidine derivatives as 5HT2/D3 modulators
03/11/2009CN101384577A Novel coumarin derivative having antitumor activity
03/11/2009CN101384560A Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
03/11/2009CN101384559A Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/11/2009CN101384558A Gaba-b receptor modulators
03/11/2009CN101384555A Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
03/11/2009CN101384554A Pyridine-2-carboxamide derivatives
03/11/2009CN101384553A Substituted aniline derivatives useful as histamine h3 antagonists
03/11/2009CN101384183A Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
03/11/2009CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same
03/11/2009CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
03/11/2009CN100467462C Terdentate ligand containing heteroaryl pyrazole, its Eu complex and electroluminescent element
03/11/2009CN100467461C N-oxyde of N-phenyl-2-pyrimidine-amine derivatives
03/11/2009CN100467456C Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/11/2009CN100466924C Corrective clothes with liner
03/10/2009US7501525 Derivatives of benzimidazole and their use as medicaments
03/10/2009US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents
03/10/2009US7501520 Regioselective halogenation of nicotine and substituted nicotines
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501449 2H -or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
03/10/2009US7501446 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors
03/10/2009US7501445 Imidazolidinone compounds
03/10/2009US7501444 3-Pyrid-3-yl- pyrazoles in which pyrazole ring is additionally substituted with a halogenated phenyl group; prenyl-protein transferase inhibitors
03/10/2009US7501440 blood sugar-reducing action; inhibit the activity of glycogen phosphorylase
03/10/2009US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
03/10/2009US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501413 Dicarboxamide derivatives
03/10/2009US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/10/2009US7501406 4-chloro-N-((R)-5,5-difluoro-2-oxo-azepan-3-yl)-N-[2-fluoro-4-(2H-[1,2,4]triazol-3-yl)-benzyl]-benzenesulfonamide; gamma -secretase inhibitor; neurodegenerative diseases; Alzheimer's disease; anticarcinogenic agent; cervical carcinomas and breast carcinomas and malignancies of the hematotic system
03/10/2009US7501404 Substituted azetidinones
03/10/2009US7501076 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance
03/10/2009CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
03/10/2009CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
03/05/2009WO2009029625A1 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors
03/05/2009WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors
03/05/2009WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/05/2009WO2009029375A1 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009029214A1 Isoquinolone derivatives as phosphodiesterase 10 inhibitors
03/05/2009WO2009028655A1 Heterocyclic compound and use thereof
03/05/2009WO2009028618A1 Piperidine derivative
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide
03/05/2009WO2009027820A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/05/2009WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
03/05/2009WO2009027736A2 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer
03/05/2009WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009027614A2 Method for splitting omeprazole salts
03/05/2009WO2009027533A1 Process for preparing 2-sulfinyl-1h-benzimidazoles
03/05/2009WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
03/05/2009WO2009027395A1 A new class of histone deacetylase inhibitors
03/05/2009WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
03/05/2009WO2009027264A1 Benzimidazole derivatives used as fxr agonists
03/05/2009WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use
03/05/2009WO2009008905A4 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
03/05/2009WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors
03/05/2009WO2009005677A3 Antiviral compounds
03/05/2009WO2009005676A3 Antiviral compounds
03/05/2009WO2008153289A3 Process for preparing bepotastine and intermediates used therein
03/05/2009WO2008147812A3 4' substituted compounds having 5-ht6 receptor affinity
03/05/2009WO2008145681A3 Ccr2 receptor antagonists and uses thereof
03/05/2009WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors
03/05/2009WO2008130651A3 Diarylisoxazolines
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors
03/05/2009WO2008023258A8 Piperidine derivatives
03/05/2009WO2008022962A3 Method for producing n-piperidinyl-benzodiazepines having cgrp-antagonistic properties
03/05/2009WO2008012441A3 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses
03/05/2009US20090062541 Reacting an aryl or heteroaryl halide with a cyanide donor,potassium hexacyanoferrate(II) or (III), in the presence of a copper compound and a 1-alkyl imidazole as a catalyst stabilizer); nontoxic; industrial scale; cost efficiency; chemical intermediates for agrochemicals and pharmaceuticals
03/05/2009US20090062537 N-Formyl Hydrozyamine Compounds
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062358 Peroxisome proliferator activated receptor alpha agonists
03/05/2009US20090062349 1-Hydroxycycloalkanecarboxamide derivatives
03/05/2009US20090062348 Antifungal Agent Containing Pyridine Derivative
03/05/2009US20090062347 Deuterated axitinib (AG-13736), N-Methyl-2-[[3- [2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide; cancer treatment
03/05/2009US20090062345 Amide derivatives as trpv1 antagonists
03/05/2009US20090062343 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/05/2009US20090062342 Amines
03/05/2009US20090062341 Nuclear receptor binding agents
03/05/2009US20090062317 Medicinal use of receptor ligands
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009US20090062306 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
03/05/2009US20090062295 Pharmaceutical Products
03/05/2009US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
03/05/2009US20090062293 1,4-Substituted Piperazine Derivatives
03/05/2009US20090062291 Phosphodiesterase 10 inhibitors
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090062281 such as 7-(2-[1,4']Bipiperidinyl-1'-yl-ethoxy)-6-methoxy-4-(4-phenoxy-phenylamino)-quinoline-3-carbonitrile, useful in the prevention of diseases associated with the Ras/Raf/MEK signaling cascade in a mammals, such as tumors, cancer, strokes, osteoporosis, arthritis and inflammatory diseases
03/05/2009US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
03/05/2009US20090062277 Phosphodiesterase 10 inhibitors
03/05/2009US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
03/05/2009US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
03/05/2009US20090062261 Nitrogen-containing heterocycle derivatives substituted with cyclic group
03/05/2009US20090062260 Compounds and compositions as lxr modulators
03/05/2009US20090060968 Inhibitors of phosphatases
03/05/2009US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use